MKD adopts Blockchain to enhance its platform
Molecular Data Inc. (NASDAQ:MKD) announced an upgrade to its platform, integrating Blockchain technology into its chemical business operations. This adoption is expected to enhance traceability and transparency, improving both the efficiency and safety of transactions. The company aims to establish credibility throughout various processes in its business model.
As a technology-driven entity in China's chemical industry, Molecular Data delivers a range of solutions including e-commerce, financial services, and logistics, addressing challenges faced by participants in the traditional chemical market.
- Integration of Blockchain technology to enhance transaction efficiency and safety.
- Improved traceability and transparency, boosting business credibility.
- None.
SHANGHAI, Dec. 6, 2021 /PRNewswire/ -- Molecular Data Inc. (NASDAQ:MKD) has upgraded its platform using Blockchain for its current chemical business.
With properties of Blockchain including traceability and transparency, such an adoption can be applied in numerous processes from the front to back end in the current business to improve credibility.
Also, the transactions efficiency and safety will be enhanced.
About Molecular Data Inc.
Molecular Data Inc. is a technology-driven platform in China's chemical industry, connecting participants along the chemical value chain through integrated solutions. The Company delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and SaaS suite that are intended to solve pain points for participants in the traditional chemical industry. Built upon a comprehensive knowledge engine and artificial intelligence (AI) capabilities, the Company's e-commerce solutions are mainly offered through its online platform, consisting of molbase.com, molbase.cn, Moku Data WeChat account, Chemical Community APP and other ancillary platforms.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "confident," "potential," "continue" or other similar expressions. Among other things, the quotations from management in this announcement, as well as the Company's strategic and operational plans, contain forward-looking statements. The Company may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about the Company's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties, and a variety of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company's goals and strategies; the Company's future business development, results of operations and financial condition; the expected growth of the chemical market; the Company's ability to monetize the user base; fluctuations in general economic and business conditions in China; the potential impact of the COVID-19 to the Company's business operations and the economy in China and elsewhere generally; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company's filings with the Securities and Exchange Commission. All information provided in this press release is as of the date of the press release, and the Company undertakes no duty to update such information, except as required under applicable law.
View original content:https://www.prnewswire.com/news-releases/mkd-adopts-blockchain-to-enhance-its-platform-301437778.html
SOURCE Molecular Data Inc.
FAQ
What recent upgrade did Molecular Data Inc. (MKD) implement?
How does Blockchain technology benefit Molecular Data Inc. (MKD)?
What services does Molecular Data Inc. (MKD) provide?
When was the press release about Molecular Data Inc. (MKD) published?
